Cargando…

T cell-derived exosomes in tumor immune modulation and immunotherapy

Exosomes are nanoscale vesicles secreted by most cells and have a phospholipid bilayer structure. Exosomes contain DNA, small RNA, proteins, and other substances that can carry proteins and nucleic acids and participate in communication between cells. T cells are an indispensable part of adaptive im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Qiujun, Wei, Shenyu, Wang, Hui, Li, Yuanyuan, Fan, Shasha, Cao, Yi, Wang, Chenglei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157026/ https://www.ncbi.nlm.nih.gov/pubmed/37153615 http://dx.doi.org/10.3389/fimmu.2023.1130033

Ejemplares similares

The Effect of Hypoxia-Induced Exosomes on Anti-Tumor Immunity and Its Implication for Immunotherapy
por: Guo, Wenwen, et al.
Publicado: (2022)

Vascular Microenvironment, Tumor Immunity and Immunotherapy
por: Lamplugh, Zachary, et al.
Publicado: (2021)

Released Exosomes Contribute to the Immune Modulation of Cord Blood-Derived Stem Cells
por: Hu, Wei, et al.
Publicado: (2020)

Exosomes Derived From Septic Mouse Serum Modulate Immune Responses via Exosome-Associated Cytokines
por: Gao, Kun, et al.
Publicado: (2019)

Immunotherapy: Reshape the Tumor Immune Microenvironment
por: LV, Bingzhe, et al.
Publicado: (2022)

Placenta-Derived Exosomes as a Modulator in Maternal Immune Tolerance During Pregnancy
por: Bai, Kunfeng, et al.
Publicado: (2021)

Research Progress in the Application of Exosomes in Immunotherapy
por: Zhang, Xiaofang, et al.
Publicado: (2022)

Dendritic Cell-Derived Exosomes may be a Tool for Cancer Immunotherapy by Converting Tumor Cells into Immunogenic Targets
por: Romagnoli, Graziela Gorete, et al.
Publicado: (2015)

Roles of the Exosomes Derived From Myeloid-Derived Suppressor Cells in Tumor Immunity and Cancer Progression
por: Chen, Zhuang, et al.
Publicado: (2022)

KSHV: Immune Modulation and Immunotherapy
por: Broussard, Grant, et al.
Publicado: (2020)

Emerging Role of Exosomes in Tuberculosis: From Immunity Regulations to Vaccine and Immunotherapy
por: Sun, Yin-Fu, et al.
Publicado: (2021)

Landscape of tumor and immune system cells-derived exosomes in lung cancer: mediators of antitumor immunity regulation
por: Castillo-Peña, Alejandro, et al.
Publicado: (2023)

Pathogenic and Potential Therapeutic Roles of Exosomes Derived From Immune Cells in Liver Diseases
por: Zhou, Leyu, et al.
Publicado: (2022)

Ultrasound-Targeted Microbubble Destruction: Modulation in the Tumor Microenvironment and Application in Tumor Immunotherapy
por: Han, Ye, et al.
Publicado: (2022)

Roles of Exosomes Derived From Immune Cells in Cardiovascular Diseases
por: Wu, Runda, et al.
Publicado: (2019)

Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy
por: Xu, Shumin, et al.
Publicado: (2023)

An emerging research: the role of hepatocellular carcinoma-derived exosomal circRNAs in the immune microenvironment
por: Xu, Huang-Zhen, et al.
Publicado: (2023)

Exosomes: A potential tool for immunotherapy of ovarian cancer
por: Gong, Xiangjin, et al.
Publicado: (2023)

Exosomes as smart drug delivery vehicles for cancer immunotherapy
por: Zhang, Huan, et al.
Publicado: (2023)

Tumor-Derived Exosomes in Immunosuppression and Immunotherapy
por: Olejarz, Wioletta, et al.
Publicado: (2020)

Tumor-derived extracellular vesicles modulate innate immune responses to affect tumor progression
por: Wang, Siqi, et al.
Publicado: (2022)

The role of tumor immune microenvironment in chordoma: promising immunotherapy strategies
por: Xu, Jiuhui, et al.
Publicado: (2023)

Immune Cell-Derived Extracellular Vesicles – New Strategies in Cancer Immunotherapy
por: Yang, Pengxiang, et al.
Publicado: (2021)

The Potential Role of circRNA in Tumor Immunity Regulation and Immunotherapy
por: Xu, Zihao, et al.
Publicado: (2018)

Editorial: The role of multi-omics variants in tumor immunity and immunotherapy
por: Chen, Shuang, et al.
Publicado: (2022)

Modulating the tumor immune microenvironment with nanoparticles: A sword for improving the efficiency of ovarian cancer immunotherapy
por: Xu, Tianyue, et al.
Publicado: (2022)

Comprehensive Analysis of the Tumor Immune Microenvironment Landscape in Glioblastoma Reveals Tumor Heterogeneity and Implications for Prognosis and Immunotherapy
por: Zhao, Rongrong, et al.
Publicado: (2022)

The Role of Tumor-Derived Exosomes in the Abscopal Effect and Immunotherapy
por: Shan, Zechen, et al.
Publicado: (2021)

Clinical application and prospect of immune checkpoint inhibitors for CAR-NK cell in tumor immunotherapy
por: Yang, Kangdi, et al.
Publicado: (2023)

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy
por: Guo, Liting, et al.
Publicado: (2021)

Recent advances in exosome-based immunotherapy applied to cancer
por: Xie, Jindong, et al.
Publicado: (2023)

Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy
por: Lin, Yi, et al.
Publicado: (2022)

Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix
por: Flies, Dallas B., et al.
Publicado: (2023)

The roles of ERIANIN in tumor and innate immunity and its’ perspectives in immunotherapy
por: Yang, Zhen, et al.
Publicado: (2023)

Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies
por: Sun, Liguang, et al.
Publicado: (2020)

Heterogeneity of tumor immune microenvironment and real-world analysis of immunotherapy efficacy in lung adenosquamous carcinoma
por: Li, Chao, et al.
Publicado: (2022)

Semen-Derived Exosomes Mediate Immune Escape and Transmission of Reticuloendotheliosis Virus
por: Su, Qi, et al.
Publicado: (2021)

DC-Derived Exosomes for Cancer Immunotherapy
por: Yao, Yi, et al.
Publicado: (2021)

Associations of HER2 Mutation With Immune-Related Features and Immunotherapy Outcomes in Solid Tumors
por: Wang, Deqiang, et al.
Publicado: (2022)

Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment
por: Zhang, Nan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_86j52igc9ru1glbvs49g1ci4k7